tetano
Editor, Senior Moderator
BMC Infect Dis. 2017 Nov 22;17(1):729. doi: 10.1186/s12879-017-2823-9.
[h=1]Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: a two-year prospective study in general practice medicine.[/h] Minodier L[SUP]1[/SUP], Masse S[SUP]1[/SUP], Capai L[SUP]1[/SUP], Blanchon T[SUP]2,[/SUP][SUP]3[/SUP], Ceccaldi PE[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], van der Werf S[SUP]5,[/SUP][SUP]7,[/SUP][SUP]8[/SUP], Hanslik T[SUP]9,[/SUP][SUP]10,[/SUP][SUP]11[/SUP], Charrel R[SUP]12[/SUP], Falchi A[SUP]13[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Gastrointestinal (GI) symptoms, such as diarrhea, vomiting, abdominal pain and nausea are not an uncommon manifestation of an acute respiratory infection (ARI). We therefore evaluated clinical and microbiological factors associated with the presence of GI symptoms in patients consulting a general practitioner (GP) for ARI.
[h=4]METHODS:[/h] Nasopharyngeal swabs, stool specimens and clinical data from patients presenting to GPs with an ARI were prospectively collected during two winter seasons (2014-2016). Samples were tested by quantitative real-time PCR for 12 respiratory pathogen groups and for 12 enteric pathogens.
[h=4]RESULTS:[/h] Two hundred and four of 331 included patients (61.6%) were positive for at least one respiratory pathogen. Sixty-nine stools (20.8%) were positive for at least one pathogen (respiratory and/or enteric). GI symptoms were more likely declared in case of laboratory confirmed-enteric infection (adjusted odds ratio (aOR) = 3.2; 95% confidence interval [CI] [1.2-9.9]; p = 0.02) or human coronavirus (HCoV) infection (aOR = 2.7; [1.2-6.8]; p = 0.02). Consumption of antipyretic medication before the consultation seemed to reduce the risk of developing GI symptoms for patients with laboratory-confirmed influenza (aOR = 0.3; [0.1-0.6]; p = 0.002).
[h=4]CONCLUSIONS:[/h] The presence of GI symptoms in ARI patients could not be explained by the detection of respiratory pathogens in stools. However, the detection of enteric pathogens in stool samples could explained by the presence of GI symptoms in some of ARI cases. The biological mechanisms explaining the association between the presence of HCoVs in nasopharynx and GI symptoms need to be explored.
[h=4]KEYWORDS:[/h] Acute respiratory infection; Enteric pathogens; Gastrointestinal symptoms; General practitioner; Influenza virus
PMID: 29166867 DOI: 10.1186/s12879-017-2823-9
Free full text
[h=1]Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: a two-year prospective study in general practice medicine.[/h] Minodier L[SUP]1[/SUP], Masse S[SUP]1[/SUP], Capai L[SUP]1[/SUP], Blanchon T[SUP]2,[/SUP][SUP]3[/SUP], Ceccaldi PE[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], van der Werf S[SUP]5,[/SUP][SUP]7,[/SUP][SUP]8[/SUP], Hanslik T[SUP]9,[/SUP][SUP]10,[/SUP][SUP]11[/SUP], Charrel R[SUP]12[/SUP], Falchi A[SUP]13[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Gastrointestinal (GI) symptoms, such as diarrhea, vomiting, abdominal pain and nausea are not an uncommon manifestation of an acute respiratory infection (ARI). We therefore evaluated clinical and microbiological factors associated with the presence of GI symptoms in patients consulting a general practitioner (GP) for ARI.
[h=4]METHODS:[/h] Nasopharyngeal swabs, stool specimens and clinical data from patients presenting to GPs with an ARI were prospectively collected during two winter seasons (2014-2016). Samples were tested by quantitative real-time PCR for 12 respiratory pathogen groups and for 12 enteric pathogens.
[h=4]RESULTS:[/h] Two hundred and four of 331 included patients (61.6%) were positive for at least one respiratory pathogen. Sixty-nine stools (20.8%) were positive for at least one pathogen (respiratory and/or enteric). GI symptoms were more likely declared in case of laboratory confirmed-enteric infection (adjusted odds ratio (aOR) = 3.2; 95% confidence interval [CI] [1.2-9.9]; p = 0.02) or human coronavirus (HCoV) infection (aOR = 2.7; [1.2-6.8]; p = 0.02). Consumption of antipyretic medication before the consultation seemed to reduce the risk of developing GI symptoms for patients with laboratory-confirmed influenza (aOR = 0.3; [0.1-0.6]; p = 0.002).
[h=4]CONCLUSIONS:[/h] The presence of GI symptoms in ARI patients could not be explained by the detection of respiratory pathogens in stools. However, the detection of enteric pathogens in stool samples could explained by the presence of GI symptoms in some of ARI cases. The biological mechanisms explaining the association between the presence of HCoVs in nasopharynx and GI symptoms need to be explored.
[h=4]KEYWORDS:[/h] Acute respiratory infection; Enteric pathogens; Gastrointestinal symptoms; General practitioner; Influenza virus
PMID: 29166867 DOI: 10.1186/s12879-017-2823-9
Free full text